The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer

By afschroeder • March 7, 2026

Leonhardt CS, Adham M, Bazarbashi S, Ben-Aharon I, Beets-Tan RGH, Boggi U, Brunner TB, Cellini F, Chiti A, Daamen L, De Bari B, De Dosso S, Ducreux M, Eng C, Falconi M, Ferrone CR, Frigerio I, Garajova I, Gerum S, Ghadimi M, Gruenberger T, Hammel P, Haustermans K, Hawkins M, He J, Heerkens HD, Huguet F, Intven MPW, Klaiber U, Kroese TE, Laurent-Puig P, Lordick F, Ludmir EB, Macarulla T, Matzinger O, Morganti AG, Mukherjee S, O'Reilly EM, Park JO, Papamichael D, Pfeiffer P, Ramia JM, Roeder F, Ruiz-García E, Satoi S, Scorsetti M, Schneider M, Seufferlein T, Serrablo A, Shrikhande SV, Smyth EC, Svrcek M, Takaori K, Tempero MA, Tissera NS, Tie J, Torres OJM, Turpin A, Van Cutsem E, Versteijne E, Vivaldi C, Wainberg ZA, Weichselbaum RR, Weitz J, Wolfgang CL, Prager GW, Strobel O. The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. Lancet Oncol. 2026 Mar;27(3):e141-e149. doi: 10.1016/S1470-2045(25)00714-4. PMID: 41785904.

Tags: Hematology/Oncology, Publications

Related Posts

American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults

O'Dwyer K, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer J, Hayes-Lattin[...]

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer

Zhang S, Queen KJ, Duggirala N, Yang E, Lipsyc-Sharf M, Racz J, Bennett J, Hong K, Suresh Y, Hamilton C, Pitta M, Chien N, La[...]

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Choueiri TK, Merchan J, Patnaik A, Drakaki A, Rini BI, Rha SY, Lee JL, Ornstein MC, Kumar R, Hwang C, Shao Y, Park SH, Barata[...]